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Abstract 
In molecular biology, CRISPR-Cas9 is a useful gene editing tool that takes advantage of 
a powerful cleaving enzyme and DNA sequences found in prokaryotes.  In this study, a target-
specific CRISPR-Cas9 vector containing an RNA-guided Cas9 nuclease specific for the FUM1 
gene was constructed for the purpose of introducing mutations into the FUM1 gene of Fusarium 
verticillioides. Plasmids pFC332 and pFC334 were isolated. A guide RNA sequence was 
designed and amplified using Polymerase Chain Reaction (PCR) with pFC334 as the template. 
Sticky ends were created through restriction enzyme digestion of pFC332. These pieces were 
combined using Uracil-Specific Excision Reagent (USER) fusion, and the resulting vector was 
transformed into competent E. coli cells. Colonies containing the constructed vector were 
selected, and PCR was performed for amplification. The results were purified and stored at -
40℃. This constructed vector can be used for the specific mutation of the FUM1 gene of 
Fusarium verticillioides.  
 
Introduction 
CRISPR-Cas9 is a gene editing tool that is becoming an important player in genetic 
research. CRISPRs, or clustered regularly interspaced palindromic repeats, are short segments of 
DNA that serve as an immune mechanism in bacteria and archaea. Cas9, or CRISPR associated 
protein 9, is a large protein that was found to be imperative in the defense against viral invasion 
in prokaryotes. It is an RNA-guided DNA endonuclease that scientists have recently taken 
advantage of for genome engineering. Use of this system requires a single guide RNA that 
includes a sequence of 20 nucleotides that align with the target DNA site and a double-stranded 
sequence that binds to Cas9. A PAM (protospacer adjacent motif) site is a 3-nucleotide sequence 
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of DNA that is essential for the proper binding of the Cas9 protein. As long as the segment of 
target DNA is adjacent to a PAM site, the system can be manipulated to work with any target. 
(Doudna and Charpentier, 2014).  
Fusarium verticillioides is one of the most commonly seen species of Fusarium and is a 
known producer of fumonisin. Fusarium is a plant pathogenic species of fungi that commonly 
infects maize, among other crops (Facchini et al., 2017), and fumonisins are known carcinogenic 
mycotoxins that were first isolated from a species of F. verticillioides in 1988. F. verticillioides 
is one of the most important producers of fumonisins, since it is geographically widespread and 
produces high levels of the toxin (Rheeder et al., 2002). Understanding the cause of 
pathogenicity brings economic and human health benefits. It gives scientists guidance for ways 
to target this species in order to make it less virulent. In addition, it allows insight for the best 
ways to protect crops from this pathogen, in turn protecting humans from a known carcinogen.  
A system has been developed for the use of CRISPR-Cas9 in filamentous fungi. Four 
vectors were prepped with commonly used selection markers, in addition to scaffolding for guide 
RNA synthesis, so that it can be adapted to be used in different species and for different target 
genes. A gene host can be transformed with a single plasmid that contains the components of the 
CRISPR-Cas9 system, the Cas9 nuclease, a gene-specific guide RNA, and the desired selection 
marker (Nodvig et al., 2015). In the spring of 2019, this system was used for the silencing of the 
yA gene in Aspergillus nidulans.  This initial study served as an introduction into the use of 
CRISPR-Cas9 systems in filamentous fungi and provided a basis for the mutation of the FUM1 
gene in Fusarium verticillioides. In addition, the protocols used for the collection of spores, 
production of protoplasts, and PEG-mediated transformation used for A. nidulans can be 
followed closely in the use of F. verticillioides.  
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Hypothesis 
In this study, a target-specific CRISPR-Cas9 vector has been constructed for the mutation 
of the FUM1 gene of Fusarium verticillioides. The successful construction of this vector was 
detected through the use of a Polymerase Chain Reaction (PCR) including the original guide 
RNA primers and the completed vector isolated from transformed competent cells as the 
template. It is hypothesized that if this CRISPR-Cas9 vector containing the FUM1 gene specific 
guide RNA and a hygromycin resistance selection marker is transformed into protoplasts of 
Fusarium verticillioides using a PEG-mediated method, then the FUM1 gene will be silenced in 
the colonies that successfully grow in a hygromycin environment. This silencing can be 
determined by using PCR analysis specific to the FUM 1 gene.  
 
Methodology 
Introduction of mutations into the yA gene of Aspergillus nidulans 
 Plasmid pFC334 was isolated from a culture that already contained it using the Thermo 
Scientific GeneJET Plasmid Miniprep Kit. The protocol provided with the kit was followed 
without any changes. The resulting plasmid DNA was run on a 1% agarose gel and used later for 
the transformation of protoplasts. When studying an agarose gel, it is important to note that the 
size of the DNA fragment determines how far it will run. Larger fragments will travel further on 
the gel than smaller fragments. Standard ladders are run with samples and used to estimate the 
size of the unknown fragments. Ethidium bromide is used to enable visibility of the DNA bands.  
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Figure 1: The gel for the isolation of pFC334 plasmid DNA, lanes are numbered from left 
to right. 
 
Well #  
1-9 pFC334 plasmid DNA 
10-18 pFC332 plasmid DNA 
19 Lambda-HindIII Standard 
20 Blank 
Table 1: Table for the gel run for isolation of pFC334 plasmid DNA.  
 
 In order to produce protoplasts of Aspergillus nidulans, spores were first collected. 
Spores were collected from colonies of A. nidulans by adding and spreading Tween in a sterile 
environment using hockey sticks and ethanol. The resulting disrupted spores were collected and 
filtered through miracloth and rinsed with the addition of more Tween. This resulting solution 
was vortexed and used for the production of protoplasts. The images taken of the microscope 
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samples show that there were indeed protoplasts during this step of the experiment. Protoplasts 
were essential for the transformation, because without them the presence of a cell wall inhibits 
the ability of a plasmid DNA to be inserted. 
 
 Spores were inoculated in 20 mLs of YT medium containing arginine and biotin as 
growth supplements while incubating and shaking overnight. Hyphae was harvested by filtration 
through miracloth and washed with growth medium. Hyphae was scraped with a spatula and 
resuspended in 8 mLs of YT solution. 8 mLs of the protoplasting solution were added after filter 
sterilization. This solution was incubated with gentle shaking for two hours. The undigested 
hyphal material was removed by layering the protoplasting mixture onto a 1.2 M sucrose cushion 
and centrifuging in a clinical centrifuge. Protoplasts were collected from the top of the sucrose 
cushion and placed in a centrifuge tube with equal volume 0.6 M KCl for centrifugation. The 
protoplasts formed a loose pellet, which was resuspended in 2 mL of 0.6 M KCl and transferred 
to two new microcentrifuge tubes. Protoplasts were again pelletized and resuspended in 0.6 M 
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KCl 3 additional times, then the pellets were finally resuspended in 0.5 mL of 0.6 M KCl and 50 
mM CaCl2. Throughout the steps of this procedure, samples were viewed under a microscope to 
monitor progress of protoplast production.  
 Ten μL of isolated pFC334 DNA were added to 100 μL protoplast suspension and mixed 
thoroughly. 50 μL of PEG solution were added and the solution was vortexed and placed in an 
ice bath for 25 minutes. 1 mL of PEG solution was added, mixed, and put in an ice bath for 25 
minutes. 100 μL were added to minimal media plates containing biotin and arginine and left to 
grow. Resulting yellow colonies were isolated and streaked on nonselective plates and left to 
grow as well. Since this plasmid is selective for arginine, the ability to grow colonies on the 
plates containing arginine confirmed that the plasmid had indeed transformed the protoplasts. 
The yellow colonies that grew from the transformation represented a successful silencing of the 
yA gene in A. nidulans, since they were lacking the green pigment. Yellow colonies were then 
chosen and grown on non-selective plates, and this resulted in rapid yellow colony growth. This 
shows that the phenotype is stable without the presence of the plasmid.  
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Figure 4: Isolated yellow colonies from transformation streaked on a non-selective plate. 
 
Construction of the FUM1 Specific Vector 
 The biggest difference between the transformation performed in Aspergillus nidulans and 
that in Fusarium verticillioides is the construction of a CRISPR-Cas9 vector specific for the 
FUM1 gene of F. verticillioides. The first step in construction was isolating plasmids pFC332 
and pFC334 (Nødvig et al, 2015). These isolations were performed using the Thermo Scientific 
GeneJET Plasmid Miniprep Kit, and the protocol provided with the kit was followed without any 
changes. Plasmid pFC332 contains the gene for hygromycin resistance, which was the chosen 
selection marker for this study. Plasmid pFC334 contains the gRNA scaffold, allowing for the 
introduction of a guide RNA specific for FUM1. The results of these isolations were analyzed by 
gel electrophoresis on a 1% agarose gel. This isolation was successful, since the bands 
represented the expected sizes for the plasmids. Plasmid pFC332 was around 15,000 base pairs 
and pFC334 was around 17,000 base pairs. Both plasmids were characterized with a restriction 
enzyme digest using EagI. This restriction enzyme was chosen because it has 5 cut sites on 
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pFC332 and only 2 sites of pFC334. This would allow for the characterization and distinction of 
the two plasmids, but a successful image was not obtained. 
 
Figure 5: The gel for the isolation of pFC332 and pFC334 plasmid DNA, lanes are 
numbered from left to right.  
 
Well #  
1 Lambda-HindIII Standard 
2-3, 8-10 pFC332 plasmid DNA 
6-7, 14-16 pFC334 plasmid DNA 
Table 2: Table for the gel run for isolation of pFC332 and pFC334 plasmid DNA.  
 
  Once the plasmids were isolated, a guide RNA specific to the FUM1 gene of Fusarium 
verticillioides was designed. The Eukaryotic Pathogen CRISPR guide RNA/DNA Design Tool 
was utilized in the design of the guide RNA sequence. This tool was chosen because it could 
compare the sequence of a target gene to the entire genome, and it had the genome of Fusarium 
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verticillioides available in its database. The Broad Institute has previously sequenced the 
complete genome of F. verticillioides and is where the sequence of the FUM1 gene was 
gathered. The FUM1 gene sequence was compared to the entire genome of F. verticillioides 
using the guide RNA design tool, and a resulting guide RNA sequence with the fewest number 
of offsite targets and a location towards the middle of the gene was chosen. Offsite targets could 
cause the CRISPR-Cas9 system to bind and cleave DNA in different areas of the genome, and a 
target sequence too early or late within the FUM1 gene could result in no impact on the gene 
expression. This is why these parameters were taken into consideration. Once a sequence was 
chosen, it was used in the building of PCR primers based on the example of primers CSN414 and 
CSN416 (Nødvig et al, 2015). The resulting primers, FUM1 Right Forward Primer 1 (5’-
AGTAAGCUCGTCATTCTCACCGACCATGTCTGTGGGTTTTAGAGCTAGAAATAGCAA
GTT-3’), and FUM1 Left Reverse Primer 1 (5’-
AGCTTACUCGTTTCGTCCTCACGGACTCATACCTTCTCCGGTGATGTCTGCTCAAGCG
-3’), were ordered from Integrated DNA Technologies along with primers CSN389 (5’-
GGGTTTAAUGCGTAAGCTCCCTAATTGGC-3’) and CSN390 (5’-GGTCTTAAU 
GAGCCAAGAGCGGATTCCTC-3’) (Nødvig et al, 2015).  
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Once the constructed primers arrived from IDT, PCR reactions were performed. Two 
separate reactions were performed: one using plasmid pFC334 as a template with FUM1 Right 
Forward Primer 1 and CSN390 and the other using pFC334 as a template with FUM1 Left 
Reverse Primer and CSN389. Sequences for primers CSN389 and CSN390 were provided by 
Nødvig et al (2015).  The results of these PCR reactions were analyzed through gel 
electrophoresis on a 1% agarose gel. The resulting fragments supported the successful 
amplification using these specific primers and the introduction of the specific guide RNA for the 
FUM1 gene. 
 
 
Figure 6: The gel for the PCR reactions of plasmid pFC334, lanes are numbered from left 
to right, bottom to top.  
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Well #  
Bottom 1 100 Base Pair Ladder Standard 
Bottom 2-13 Primers FUM1 Right Forward Primer 1 and 
CSN390 
Top 1 pFC334 plasmid DNA 
Top 2-13 Primers FUM1 Left Reverse Primer 1 and 
CSN389 
Table 4: Table for the gel run for the PCR reactions of plasmid pFC334.  
 
In order to construct the vector, plasmid pFC332 was digested with the restriction 
enzymes PACI and Nt.BbvCI. For the restriction enzyme digest, 15 μL of plasmid pFC332 were 
combined with 1 μL PACI, 1 μL Nt.BbvCI, 2 μL cutsmart buffer, and 1 μL of distilled water. 
This reaction was combined in a microcentrifuge tube and left to incubate overnight at 37℃. The 
next day, an additional microliter of Nt.BbvCI was added to the mixture and left to incubate for 
one hour. This step was included to increase the efficiency of the enzyme. This reaction was 
purified using the Thermo Scientific GeneJET Gel Extraction and DNA Cleanup Micro Kit. The 
protocol provided with the kit was followed without any modifications. This restriction enzyme 
digest provided sticky ends, which are important for the introduction of the guide RNA using 
Uracil-Specific Excision Reagent (USER) fusion.  
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USER fusion is a powerful technique that allows the cloning and ligation of several PCR 
fragments into a vector in one relatively quick and simple step. In this study, USER fusion 
allowed for the construction of the vector in one step, ligating the two plasmid pFC334 PCR 
products with the purified restriction enzyme digest of plasmid pFC332 (New England Biolabs). 
The PCR products were diluted 1:5 in distilled water. 1 μL of Thermolabile USER II Enzyme 
was combined with 1 μL of each dilute PCR product, 1 μL of the purified restriction enzyme 
digest plasmid, and 6 μL of cutsmart buffer. This mixture was incubated for 20 minutes at 37℃, 
followed by 25 minutes at room temperature. It was then directly transformed into competent E. 
coli cells.  
For the transformation of E. coli, all 10 μL of the USER fusion reaction were added to the 
tube of competent cells and left to chill on ice for 30 minutes. The tube was heat shocked at 42℃ 
for 90 sec before being chilled for another 90 sec. 800 μL SOC were added and the tube was 
incubated in a 37℃ heat bath at 225 RPM for one hour. The results were spread in a sterile 
environment with a hockey stick and flaming alcohol on agar plates containing ampicillin. In this 
step of the experiment, ampicillin resistance was used as the selection marker. Only cells that 
had been transformed with the constructed vector would survive in the presence of ampicillin, 
and these colonies were isolated and amplified using colony PCR. Primers CSN389 and CSN390 
were used as primers in this PCR reaction in order to amplify the constructed vector.  
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Figure 7: The gel for colony PCR using primers CSN389 and CSN390, lanes are numbered 
from left to right. 
 
Well #  
1, 3, 5-10, 12-13, 15-16 Successful USER fusion and transformation 
17 Lambda-HindIII Standard 
Table 5: Table for the gel run for colony PCR using primers CSN389 and CSN390.  
 
The Thermo Scientific GeneJET Plasmid Miniprep Kit was used for purification of the 
amplified plasmids that represented successful USER fusion, and the protocol was followed 
without any changes. The results of the isolation were analyzed by gel electrophoresis on a 1% 
agarose gel. The corresponding fragments suggest that the isolation of this vector was successful. 
This purified vector will be used directly in the transformation of Fusarium verticillioides.  
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Figure 8: The gel for the isolation of the constructed FUM1-specific CRISPR-Cas9 vector, 
lanes are numbered from left to right. 
 
 
Well #  
1 Lambda-HindIII Standard 
10-17 Isolated FUM1-Specific CRISPR-Cas9 
Vector 
 
Table 6: Table for the gel run for the isolation of the constructed FUM1-specific CRISPR-
Cas9 vector.  
 
Another PCR reaction was performed to check that both PCR fragments had been 
incorporated into the vector. The primers used in the initial PCR of plasmid pFC334 were used 
in two separate reactions, and the results were analyzed using gel electrophoresis on a 1% 
agarose gel. The expected fragments were visible, supporting the successful construction of the 
FUM1 specific vector.  
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 Figure 9: The gel for the PCR reactions of the constructed FUM1-specific CRISPR-Cas9 
vector, lanes are numbered from left to right. 
 
Well #  
1 Lambda-HindIII Standard 
2, 4, 6 Primers FUM1 Left Reverse Primer 1 and 
CSN389 
3, 5, 7 Primers FUM1 Right Forward Primer 1 and 
CSN390 
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Table 6: Table for the gel run for the PCR reaction of the constructed FUM1-specific 
CRISPR-Cas9 vector.  
 
Due to time constraints in response to the COVID-19 outbreak, this is as far as the 
research was able to be completed. The subsequent sections reflect the protocol that was 
intended for the final steps of the procedure, and the anticipated results for if the project is ever 
able to be completed.  
 
Collection of Spores 
 In order to produce protoplasts of Fusarium verticillioides, spores will first be collected. 
Spores will be collected from colonies of F. verticillioides by adding and spreading 0.01% 
Tween 80 in a sterile environment using hockey sticks and ethanol. The resulting disrupted 
spores will be collected and filtered through miracloth and rinsed with the addition of more 
0.01% Tween 80. The resulting solution will be vortexed and used for the production of 
protoplasts (Szewczyk, 2006).  
 
Production of Protoplasts 
 Spores will be inoculated in 20 mLs of fusarium medium and incubated and shaken 
overnight at 30℃. Hyphae will be harvested by filtration through miracloth and washed with 
growth medium. Hyphae will be scraped with a spatula and resuspended in 8 mLs of CM 
solution. 8 mLs of the protoplasting solution will be added after filter sterilization. This solution 
will be incubated with gentle shaking for two hours. The undigested hyphal material will be 
removed by layering the protoplasting mixture onto a 1.2 M sucrose cushion and centrifuging in 
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a clinical centrifuge. Protoplasts will be collected from the top of the sucrose cushion and placed 
in a centrifuge tube with equal volume 0.6 M KCl for centrifugation. The protoplasts will form a 
loose pellet, which will be resuspended in 2 mL of 0.6 M KCl and transferred to two new 
microcentrifuge tubes. Protoplasts will again be pelletized and resuspended in 0.6 M KCl 3 
additional times, then the pellets will finally be resuspended in 0.5 mL of 0.6 M KCl and 50 mM 
CaCl2. Throughout the steps of this procedure, samples will be viewed under a microscope to 
record progress of protoplast production. (Szewczyk, 2006) 
 
Transformation 
 To begin the transformation, 10 μL of the constructed CRISPR-Cas9 vector will be added 
to 100 μL protoplast suspension and mixed thoroughly. 50 μL of PEG solution will be added and 
the solution will be vortexed and placed in an ice bath for 25 minutes. 1 mL of PEG solution will 
be added, mixed, and put in an ice bath for 25 minutes. 100 μL will be added to Fusarium 
complete media containing hygromycin. Resulting colonies will be isolated and streaked on 
hygromycin plates and left to grow as well (Szewczyk, 2006). 
 
Conclusion 
 Due to the clear phenotypic results of the growth of yellow colonies, it is concluded that 
the mutation of the yA gene in Aspergillus nidulans was successful. This initial step provided a 
useful introduction to the use of a CRISPR-Cas9 system for genetic editing in filamentous fungi. 
Familiarity with this system was essential for the transition to use in Fusarium verticillioides, a 
fungus that has frequented far fewer studies than A. nidulans. The primary use of the CRISPR-
Cas9 system in A. nidulans greatly supported the construction of the CRISPR-Cas9 vector 
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specific for the FUM1 gene in F. verticillioides and the protocols to be followed in the collection 
of spores, production of protoplasts, and eventual transformation.  
 It is concluded that a successful construction of a target-specific CRISPR-Cas9 vector 
occurred. This is based on the results of the final PCR, showing the presence of both initial PCR 
fragments containing the guide RNA in the transformed colonies of E. coli. This isolated plasmid 
has been stored at -40℃ with the intentions of being used in the future PEG-mediated 
transformation of Fusarium verticillioides protoplasts. While it has been concluded that the 
intended plasmid has been constructed, it cannot be concluded whether this vector is successful 
in the mutation of the FUM1 gene without the introduction of the plasmid to the fungal pathogen 
and analysis of the corresponding results. 
 It is anticipated that in the event of a successful transformation of F. verticillioides 
protoplasts with this target-specific CRISPR-Cas9 vector, the FUM1 gene would be silenced. 
This could be detected with the use of hygromycin resistance as a selection marker. Since the 
constructed vector consists of a gene for hygromycin resistance, colonies could be grown and 
selected from plates containing hygromycin. The successful growth on these plates would 
support the successful transformation of this vector, and colony PCR could be performed on 
these colonies to amplify and eventually sequence the final product. This final sequencing 
information would give insight as to if the FUM1 gene had been disrupted by comparing it with 
the sequence of the gene in a wild-type colony that had not been transformed.  
Strains of Fusarium verticillioides with a disrupted FUM1 gene fail to produce detectable 
levels of fumonisins, a known carcinogen (Alberts et al., 2017). The silencing of the FUM1 gene 
would provide colonies of Fusarium verticillioides that are potentially less pathogenic. These 
colonies could be grown and studied to further conclude whether or not the FUM1 gene had been 
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disrupted, the importance of FUM1 in pathogenicity, and perhaps offer insight into combating 
the pathogenicity of Fusarium verticillioides.  Having a better understanding for what is causing 
pathogenicity allows scientists to better target and treat crops to protect against this species. This 
can lead to economic and human health benefits, making it an important research concern.  
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